@article{7d3b4a1ae7544df09f9ba503adf1e1c3,
title = "Reply: On Evaluating Out-of-Hospital 30-Day Mortality After TAVR",
author = "Saif Anwaruddin and Nimesh Desai and Sreekanth Vemulapalli and Reardon, {Michael J.}",
note = "Funding Information: Dr. Anwaruddin has served on the advisory board and received speaker fees for Medtronic; has received speaking/consulting fees from Edwards Lifesciences; has received speaking fees from Siemens; has been a proctor/consultant for V wave; and has served on the advisory board for OpSens. Dr. Desai has received speaker/consultant fees for Gore and Medtronic. Dr. Vemulapalli has served on the advisory board and received consulting fees for Boston Scientific, Heartflow, Baylabs (Caption Health), Janssen, and American College of Physicians; has received grants/contracts for Abbott Vascular, Boston Scientific, National Institutes of Health, Patient Centered Outcomes Research, Nest (FDA), American College of Cardiology, and Society of Thoracic Surgeons GMG; has received a grant from Canadian Institute of Health Sciences; and has received honorarium from Servier and Novartis. Dr. Reardon has served on the advisory board for Medtronic and Boston Scientific; and has been a consultant for Gore.",
year = "2021",
month = may,
day = "10",
doi = "10.1016/j.jcin.2021.03.037",
language = "English (US)",
volume = "14",
pages = "1040--1041",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier",
number = "9",
}